The CB2 Cannabinoid Receptor Was Required for Nicotine's Rewarding Effects but Not Withdrawal
Mice lacking CB2 cannabinoid receptors did not develop nicotine place preference, and a CB2 antagonist blocked nicotine reward, but CB2 played no role in nicotine withdrawal or acute effects.
Quick Facts
What This Study Found
Using both pharmacological (drug) and genetic (knockout mice) approaches, researchers found that CB2 receptors are essential for nicotine's rewarding effects. Nicotine-induced conditioned place preference was completely blocked by the CB2 antagonist SR144528 and was absent in CB2 knockout mice.
Conversely, the CB2 agonist O-1966, when combined with a sub-threshold nicotine dose, produced place preference. Interestingly, for cocaine the pattern was opposite: the CB2 agonist blocked cocaine reward, while CB2 knockout mice showed normal cocaine reward. CB2 receptors played no role in nicotine withdrawal symptoms or acute somatic effects like hypothermia and pain reduction.
Key Numbers
Nicotine CPP blocked by SR144528 (3 mg/kg). Absent in CB2 knockout mice. CB2 agonist O-1966 (1-20 mg/kg) + subthreshold nicotine = CPP. O-1966 (20 mg/kg) blocked cocaine CPP. CB2 knockout: normal cocaine CPP, normal nicotine withdrawal.
How They Did This
Conditioned place preference paradigm in wild-type mice with CB2 antagonist/agonist, and in CB2 knockout mice. Nicotine withdrawal precipitated with mecamylamine in nicotine-dependent mice. Acute nicotine effects (hypothermia, hypoalgesia) tested in CB2 knockout mice.
Why This Research Matters
This study revealed that CB2 receptors, previously thought to be mainly peripheral immune receptors, play a critical role in nicotine reward. The opposing roles in nicotine versus cocaine reward suggest sophisticated and substance-specific cannabinoid modulation of addiction.
The Bigger Picture
The finding that CB2 receptors play opposite roles in nicotine and cocaine reward adds complexity to our understanding of how the endocannabinoid system modulates addiction. It suggests that CB2-targeted medications for addiction would need to be substance-specific.
What This Study Doesn't Tell Us
Mouse conditioned place preference may not fully model human addiction. Genetic knockout creates lifelong absence, which may cause compensatory changes. Only one pharmacological antagonist and agonist were tested. The mechanism by which CB2 mediates nicotine reward was not identified.
Questions This Raises
- ?Could CB2-targeted drugs help treat nicotine addiction in humans?
- ?Why do CB2 receptors play opposite roles for nicotine versus cocaine?
- ?Where in the brain are CB2 receptors mediating nicotine reward?
Trust & Context
- Key Stat:
- CB2 receptors played opposite roles in nicotine reward (required) vs. cocaine reward (inhibitory)
- Evidence Grade:
- Animal study with complementary pharmacological and genetic approaches; preliminary but well-controlled evidence.
- Study Age:
- Published in 2013. CB2 receptor involvement in addiction has become an emerging research area.
- Original Title:
- The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.
- Published In:
- Psychopharmacology, 229(4), 591-601 (2013)
- Authors:
- Ignatowska-Jankowska, Bogna M(5), Muldoon, Pretal P(4), Lichtman, Aron H(28), Damaj, M Imad
- Database ID:
- RTHC-00689
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How are the cannabinoid and nicotine systems connected?
This study showed that CB2 cannabinoid receptors are required for nicotine to produce its rewarding effects in mice. Without functional CB2 receptors, nicotine did not create a place preference. This means the endocannabinoid system is directly involved in processing nicotine's rewarding signal, though the exact brain circuits involved remain to be identified.
Could cannabis-related drugs help people quit smoking?
This study suggests CB2 receptor manipulation could theoretically affect nicotine reward. A CB2 antagonist blocked nicotine place preference. However, the opposite effect on cocaine (CB2 agonist blocked cocaine reward) shows these interactions are substance-specific and complex. Much more research is needed before any clinical applications could be developed.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00689APA
Ignatowska-Jankowska, Bogna M; Muldoon, Pretal P; Lichtman, Aron H; Damaj, M Imad. (2013). The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.. Psychopharmacology, 229(4), 591-601. https://doi.org/10.1007/s00213-013-3117-6
MLA
Ignatowska-Jankowska, Bogna M, et al. "The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.." Psychopharmacology, 2013. https://doi.org/10.1007/s00213-013-3117-6
RethinkTHC
RethinkTHC Research Database. "The cannabinoid CB2 receptor is necessary for nicotine-condi..." RTHC-00689. Retrieved from https://rethinkthc.com/research/ignatowska-jankowska-2013-the-cannabinoid-cb2-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.